CSIR-IGIB and Serum Institute of India sign a tech transfer pact to develop an indigenous, affordable CRISPR-based ...
The launch of BIRSA 101 marks a major breakthrough in CRISPR gene-editing technology, positioning India to deliver affordable ...
The world-class, low-cost gene editing solution named "BIRSA 101", in honour of Bhagwan Birsa Munda, remembered as a great ...
IGIB and the Serum Institute of India aims to make sickle cell treatment accessible to India's tribal communities, where the ...
In a landmark moment for Indian science, Union Minister of State (Independent Charge) for Science & Technology Dr Jitendra ...
India has launched BIRSA 101, the nation’s first indigenous CRISPR-based gene therapy for Sickle Cell Disease, marking a ...
12don MSN
India will start clinical trial for treating sickle cell disease among central India tribal
On the occasion of Janjatiya Gaurav Divas, the Council for Scientific and Industrial Research Institute of Genomic and ...
The gene editing solution for Sickle Cell Disease, a chronic, single-gene disorder that causes a debilitating systemic syndrome characterised by chronic anaemia ...
To understand how microarray technology is evolving to meet growing scientific demands, Technology Networks spoke with Thermo ...
After releasing two gene-edited rice varieties in May this year, scientists are now focusing on developing GE varieties of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback